D'Orazio & Associates’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$511K Buy
5,572
+2,154
+63% +$188K 0.06% 130
2026
Q1
$291K Buy
3,418
+321
+10% +$28.6K 0.04% 200
2025
Q4
$245K Sell
3,097
-154
-5% -$12.1K 0.03% 226
2025
Q3
$260K Sell
3,251
-313
-9% -$26.7K 0.03% 212
2025
Q2
$324K Sell
3,564
-320
-8% -$29.2K 0.05% 158
2025
Q1
$364K Buy
3,884
+902
+30% +$80.8K 0.06% 135
2024
Q4
$271K Buy
2,982
+120
+4% +$11.5K 0.04% 169
2024
Q3
$297K Buy
2,862
+108
+4% +$11K 0.04% 156
2024
Q2
$267K Buy
+2,754
New +$254K 0.04% 150
2021
Q4
– Sell
-738
Closed -$56K – 213
2021
Q3
$56K Buy
+738
New +$58.6K 0.01% 187

Other funds holding CL

D'Orazio & Associates's CL Position: Q2 2026 in Review

D'Orazio & Associates increased its Colgate-Palmolive (CL) stake by 63% in Q2 2026, buying an estimated $188K and bringing the position to 5,572 shares worth $511K. The position accounts for 0.06% of the portfolio, ranked #130.

D'Orazio & Associates first reported a position in CL in Q3 2021 and has held it in 10 quarters since. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • D'Orazio & Associates held 5,572 shares of Colgate-Palmolive worth $511K as of Q2 2026.
  • D'Orazio & Associates bought 2,154 Colgate-Palmolive shares in Q2 2026, an estimated $188K.
  • Colgate-Palmolive made up 0.06% of D'Orazio & Associates's portfolio in Q2 2026, its #130 holding.
  • D'Orazio & Associates first reported a position in Colgate-Palmolive in Q3 2021 and has held it in 10 quarters since.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on D'Orazio & Associates's 13F filing for Q2 2026, filed 28 Jul 2026.